Last reviewed · How we verify
Creation of a serum biobank
Creation of a serum biobank is a Biologic drug developed by Hospices Civils de Lyon. It is currently in Phase 1 development.
At a glance
| Generic name | Creation of a serum biobank |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients (NA)
- Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Creation of a serum biobank CI brief — competitive landscape report
- Creation of a serum biobank updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI
Frequently asked questions about Creation of a serum biobank
What is Creation of a serum biobank?
Creation of a serum biobank is a Biologic drug developed by Hospices Civils de Lyon.
Who makes Creation of a serum biobank?
Creation of a serum biobank is developed by Hospices Civils de Lyon (see full Hospices Civils de Lyon pipeline at /company/hospices-civils-de-lyon).
What development phase is Creation of a serum biobank in?
Creation of a serum biobank is in Phase 1.
Related
- Manufacturer: Hospices Civils de Lyon — full pipeline
- Compare: Creation of a serum biobank vs similar drugs
- Pricing: Creation of a serum biobank cost, discount & access